The Quality and Reliability of Information in the Summaries of Product Characteristics

被引:2
|
作者
Drelich, Ewelina [1 ]
Religioni, Urszula [2 ]
Chung, Kevin [3 ]
Kazmierczak, Justyna [4 ]
Blicharska, Eliza [5 ]
Neumann-Podczaska, Agnieszka [6 ]
Krysinski, Jerzy [1 ]
Merks, Piotr [7 ]
机构
[1] Coll Med Bydgoszcz, Dept Pharmaceut Technol, Fac Pharm, PL-85067 Bydgoszcz, Poland
[2] Ctr Postgrad Med Educ Warsaw, Sch Publ Hlth, PL-01826 Warsaw, Poland
[3] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada
[4] Zdrowit Sp Zoo, Pharm Chain, Ul Diamentowa 3, PL-41940 Piekary Slaskie, Poland
[5] Med Univ Lublin, Dept Analyt Chem, Chodzki 4a, PL-20093 Lublin, Poland
[6] Poznan Univ Med Sci, Chair & Dept Palliat Med, PL-61245 Poznan, Poland
[7] Cardinal Stefan Wyszynski Univ Warsaw, Dept Pharmacol & Clin Pharmacol, Coll Med, Fac Med, PL-01938 Warsaw, Poland
关键词
SmPC; medicinal product; patient safety; medication handling; CHARACTERISTICS SMPC; DRUG-INTERACTIONS; RECOMMENDATIONS;
D O I
10.3390/ijerph19042185
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The Summary of Product Characteristics (SmPC) is an obligatory document concerning a medicine required (among other things) for the authorization of a medicinal product. The purpose of the SmPC is to provide product information to healthcare professionals. A necessary condition for this is to ensure that the SmPC is clear and precise. However, neither European nor national legislation obliges marketing authorization holders to review the SmPC in terms of its readability and understandability prior to the registration of a medicine. To date, research on SmPCs has focused on accuracy and completeness; however, the literature lacks information on the extent to which SmPCs meet the needs of healthcare professionals concerning the readability of the information they contain. The main objective of this article is to point out the lack of precision in the legal provisions for the preparation of SmPCs concerning the comprehensibility of the provisions. The article points to the lack of testing of the SmPC in terms of accessibility and transparency for healthcare professionals, highlighting that the document does not meet the needs of healthcare professionals in providing adequate information about medicines. It shows that the current rules and guidelines for the preparation of the registration dossier for a medicinal product are not entirely precise and contain numerous shortcomings.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Clinical pharmacology information in summaries of product characteristics and package inserts
    Arguello, B.
    Fernandez-Llimos, F.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 82 (05) : 566 - 571
  • [2] Assessing the information in the Summaries of Product Characteristics for the use of medicines in pregnancy and lactation
    Arguello, Blanca
    Salgado, Teresa M.
    Fernandez-Llimos, Fernando
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 79 (03) : 537 - 544
  • [3] Clinical relevance of information in the Summaries of Product Characteristics for dose adjustment in renal impairment
    Teresa M. Salgado
    Blanca Arguello
    Fernando Martinez-Martinez
    Shalom I. Benrimoj
    Fernando Fernandez-Llimos
    [J]. European Journal of Clinical Pharmacology, 2013, 69 : 1973 - 1979
  • [4] Clinical relevance of information in the Summaries of Product Characteristics for dose adjustment in renal impairment
    Salgado, Teresa M.
    Arguello, Blanca
    Martinez-Martinez, Fernando
    Benrimoj, Shalom I.
    Fernandez-Llimos, Fernando
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (11) : 1973 - 1979
  • [5] Evaluation of Information in Summaries of Product Characteristics (SmPCs) on the Use of a Medicine in Patients With Hepatic Impairment
    Weersink, Rianne A.
    Timmermans, Lotte
    Monster-Simons, Margje H.
    Mol, Peter G. M.
    Metselaar, Herold J.
    Borgsteede, Sander D.
    Taxis, Katja
    [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [6] AVAILABILITY OF INFORMATION ABOUT OLD PERSONS IN EUROPEAN PUBLIC ASSESSMENT REPORTS AND SUMMARIES OF PRODUCT CHARACTERISTICS
    Beers, E.
    Jansen, P. A. F.
    Egberts, A. C. G.
    Leufkens, H. G. M.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 72 - 72
  • [7] Product quality and reliability
    Lukacevic, Z
    Vitez, I
    Maglic, L
    [J]. METALURGIJA, 1999, 38 (04): : 251 - 256
  • [8] DISCORDANCES IN THE CLASSIFICATION OF RENAL IMPAIRMENT IN SUMMARIES OF PRODUCT CHARACTERISTICS
    Salgado, Teresa M.
    Arguello, Blanca
    Benrimoj, Shalom I.
    Fernandez-Llimos, Fernando
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 391 - 391
  • [9] Information in summaries of product characteristics about use in children is limited and needs standardisation: a systematic analysis in Switzerland
    Tilen, Romy
    Berger, Christoph
    Allemann, Samuel
    zu Schwabedissen, Henriette Meyer
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2024, 109 (07) : 586 - 591
  • [10] Assessment of completeness and applicability of summaries of product characteristics regarding information on fertility and drug use in pregnancy and breastfeeding
    Arguello, B.
    Salgado, T. M.
    Fernandez-Llimos, F.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1270 - 1270